Change country:

Alabama high school football game shooting leaves several wounded, police say

At least four people were shot during an Alabama high school football game on Friday night, police said.
Read full article on:
The IOC’s Treatment of Missing Chinese Tennis Star Peng Shuai Is Disturbingly On-Brand
Photo Illustration by Thomas Levinson/The Daily Beast/GettyLast week, Human Rights Watch addressed a public letter to the International Olympic Committee, a kleptocracy that owns and operates the Summer and Winter Olympic Games, calling on the IOC to stop promoting “Chinese state propaganda” regarding tennis star Peng Shuai’s sexual-assault allegations against former People’s Republic of China Vice Premier Zhang Gaoli, and subsequent disappearance.“The IOC has vaulted itself from silence about Beijing’s abysmal human rights record to active collaboration with Chinese authorities in undermining freedom of speech and disregarding alleged sexual assault,” read the letter, quoting Yaqiu Wang, a policy researcher at Human Rights Watch. “The IOC appears to prize its relationship with a major human rights violator over the rights and safety of Olympic athletes.”There’s something bitterly funny about HRW shaming the IOC for promoting authoritarianism, because even a cursory reading of the history of the IOC is crystal clear on the matter: the IOC loves enabling authoritarianism. Can’t get enough of it. Telling the IOC to stop collaborating with violent, autocratic forces is like telling your dog to stop eating cat poop from the litter box. Sure, they might look at you with sad ol’ eyes for a second, but they’re just jonesing for another bite of that precious, delicious dung.Read more at The Daily Beast.
9 m
Why Joe Biden Should Want Donald Trump to Run Again
While Democrats might despise the former president, his presence in a race could provide a clearer route to take tactically.
Omicron COVID Variant Symptoms Compared to Delta, Other Forms of the Virus
The South African doctor who first reported the Omicron variant says she noticed two common symptoms were missing from patients with this form of coronavirus.
Sea Lion Caught by Police After Going for Wander Around Oregon City
The sea lion was spotted in Lincoln City after swimming up the river and making its way through a neighbourhood.
No, the Ghislaine Maxwell Trial Does Not Have a Gag Order
Several social media posts have claimed that members of the press have been barred from accessing the courtroom.
How Boeing Was Set on the Path to Disaster by the Cult of Jack Welch
JASON REDMONDOn April 20 this year, a group of the largest stakeholders in Boeing took part in a virtual version of the company’s annual general meeting. A few hours before the meeting opened online, they learned something that took them by surprise: The retirement age for the top job, CEO of the aerospace colossus, was suddenly being raised from 65 to 70.This meant that the current CEO, Dave Calhoun, who was 64, could enjoy at least another five years in the job. A move like that would normally indicate that the stakeholders were so pleased with the way a company was being run that they thought the best way of keeping it that way was to leave the boss in place rather than replace him.But this was Boeing, and the company had never been in worse shape. Calhoun had been in charge since January 2020. In that time, its previously stellar reputation for engineering excellence had been publicly shredded after two crashes of its newest jet, the 737MAX, had killed 346 people, because of serious failures in Boeing’s safety regimen. At the same time, other airplane programs, both commercial and military, were plagued with problems, and its effort to catch up with Elon Musk’s SpaceX program supplying astronaut-carrying capsules to NASA suffered repeated and ignominious failures.Read more at The Daily Beast.
Alleged Epstein madame Ghislaine Maxwell on trial — here’s what to expect
Ghislaine Maxwell, the accused longtime madame of pedophile financier Jeffrey Epstein, will go on trial Monday -- beginning the final act of criminal proceedings.
Jussie Smollett's trial starts today. This is how we got here
Jury selection starts Monday in the trial of former "Empire" star Jussie Smollett, who is accused of making false reports to authorities that he was the victim of a racist and homophobic attack in 2019.
Lauren Boebert Says Ghislaine Maxwell Trial Will Spur 'Misguided Outrage'
Ghislaine Maxwell is accused of grooming underage girls to have sex with convicted paedophile Jeffrey Epstein.
NFL Week 13 best bets: Two games with intriguing early odds
Week 12 of the NFL season offered plenty of surprises, but will Week 13 offer more value for bettors? Here are two games worth your time and money.
Cardiac Angiosarcoma Symptoms Explained As Virgil Abloh, Off-White Founder, Dies
The influential fashion designer, 41—who was creative director for Louis Vuitton—had been receiving treatment for the cancer privately for more than two years.
Stalled since June, Iran nuclear talks to resume
The US and its allies will restart Iran nuclear talks unsure how Tehran's new government will approach negotiations, not optimistic about the prospects ahead and emphasizing that if diplomacy fails, the US is "prepared to use other options." CNN's Nic Robertson reports.
5 things to know for November 29: Coronavirus, Iran, Capitol riot, Taiwan, Arbery
Here's what else you need to know to Get Up to Speed and On with Your Day.
From Waukesha to San Francisco | Opinion
The deadly actions of the last few days should serve as a wake-up call to most Americans.
The New COVID Drugs Are a Bigger Deal Than People Realize
Although masks, distancing, ventilation, testing, and contact tracing have all helped forestall a collapse of the American health-care system under the weight of COVID-19, the pandemic will come under control in only two ways: Preventives—specifically vaccines—will harness people’s immune system to keep them from becoming infected, getting sick, and spreading the coronavirus, while targeted therapeutics will offer hope to those who have already developed symptoms. The emergence of Omicron, a worrisome new variant of the coronavirus, underscores the need to use multiple tools to fight the disease. In infectious diseases, control of a pathogen means reducing its impact even if it remains endemic in the world. Fortunately, the United States is poised to authorize two oral antivirals: molnupiravir and Paxlovid. The former is the generic name of a drug made by Merck; the latter is the trade name of a drug combination made by Pfizer. Both come in pill form, and a five-day treatment course of each will provide certain patients with significant benefits.These miraculous drugs arrived with minimal fanfare but represent the biggest advance yet in treating patients already infected with COVID-19. The supply of vaccines in the U.S. has exceeded demand for some time, and authorities recently widened eligibility to include children as young as 5, but uptake is not universal. Millions of Americans have decided, for a variety of reasons, not to get shots, while many more around the globe have yet to be offered a vaccine. And although the vaccines have remained amazingly effective against severe disease, some patients, especially those who are older or immunocompromised, remain at risk of hospitalization if they get a breakthrough infection. The widespread use of oral treatments for influenza hints at the value of COVID drugs that can be provided in an outpatient setting and reduce the severity of symptoms for unvaccinated and vaccinated patients alike.[Read: Timing is everything for Merck’s COVID pill]Molnupiravir and Paxlovid are particularly exciting because antivirals that effectively target viruses at specific points in their life cycle are the “holy grail” of viral therapeutics—as past experience with other viruses has shown. Infection with HIV was fatal for nearly all patients until antivirals were developed against enzymes crucial to viral replication and researchers figured out how to combine those drugs to maximize their effectiveness and limit the emergence of resistant viral strains. These changes revolutionized HIV treatment, massively improving the prognosis for people who had access to antivirals. Instead of developing severe illness, treated patients could live healthily and expect normal life spans.The development of these highly active oral antivirals for HIV infection took a decade and a half after the disease first came to light; the incredible progress in COVID-19 therapeutics took 18 months. Intriguingly, the COVID-19-treatment research borrowed many ideas from the HIV field; the two new COVID-19 drugs focus on similar pathways in the viral life cycle that HIV drugs target. In essence, these drugs prevent the target virus from reproducing itself. Because they work differently from the majority of COVID-19 vaccines, which teach the immune system to identify and attack the coronavirus’s characteristic spike protein, the antivirals remain effective against mutant variants whose spike proteins are harder for immune cells to recognize. Designing, manufacturing, and distributing vaccines updated for new variants will take time, so the availability of antivirals will be all the more essential.The rapid development of vaccines against COVID-19—something that doesn’t yet exist for HIV—has overshadowed the progress on treatments. And yet, the need and public demand for effective medications is evident. Doctors and patients have sought out potential oral COVID-19 treatments, including drugs such as hydroxychloroquine and ivermectin, that did not prove effective in clinical trials. But researchers needed to keep working on the question, because COVID-19 will be with us for the long haul. Although health experts agree that preventing a disease is better than treating its symptoms, not everyone will get vaccinated. People who become infected are worthy of compassion and care, regardless of the circumstances of their infection, and medical treatments that shorten the period of viral transmission and keep unvaccinated COVID-19 patients out of hospital beds will protect everyone.The COVID-19 treatments that have shown some effectiveness up to this point have significant drawbacks. Remdesivir is an intravenous antiviral used for hospitalized patients with COVID-19. But by the time a patient is admitted, the virus may already have caused considerable damage, and viral replication may have stopped. An intravenous drug has far less power to affect the trajectory of the pandemic than affordable, effective, and short courses of oral pills do. Until now, the only outpatient therapeutic for COVID-19 has been monoclonal antibody treatments, which are effective in preventing severe disease in high-risk patients. But they are expensive and require intravenous infusion or subcutaneous injection, and health-care providers must monitor their administration closely.Although molnupiravir—which is named after the Norse god Thor’s hammer, Mjollnir—was being tested for the treatment of the Ebola virus, researchers had not settled upon a purpose for the drug before SARS-CoV-2 arrived on the scene. Early studies of molnupiravir showed that its recipients cleared the coronavirus more rapidly than recipients of a placebo did. The drug did not help patients who were already hospitalized, but in outpatients with mild to moderate disease who had a high vulnerability to severe disease, it reduced the risk of hospitalization or death by 30 percent if given within five days of developing symptoms. The drug proved so beneficial that the clinical study was called off early. Merck applied for emergency-use authorization, and the FDA is expected to review the drug this week. Merck has promised to share its technology with the Medicines Patent Pool (MPP), which will allow for more affordable global access to molnupiravir.Paxlovid, a formula developed largely from scratch for the current pandemic, is actually an RNA-virus protease inhibitor called PF-07321332 “boosted” with another drug called ritonavir. It too was the subject of a clinical trial that was stopped early because the treatment looked so effective. Outpatients who had both COVID-19 and medical conditions that put them at high risk of severe illness were 89 percent less likely to be hospitalized if they received Paxlovid twice daily for five days than if they got a placebo. The FDA will likely review this important therapeutic before the end of the year. The U.S. government has bought millions of courses of molnupiravir and Paxlovid for Americans in anticipation of the authorization of both. Moreover, Pfizer has promised to accelerate worldwide access to Paxlovid through an agreement with MPP.[Read: A much-hyped COVID-19 drug is almost identical to a black-market cat cure]The importance of these two highly anticipated outpatient antivirals for COVID-19 cannot be overstated. Both medications were studied in unvaccinated individuals, of which the U.S. and other countries around the world have many. For the vaccinated, “breakthrough” infections are generally mild, but they can lead to time out of work and require cutting back contact with others. Not only should rapid treatment with one of these two antivirals shorten symptoms in breakthrough infections (as is the case with influenza), but bringing down the viral load quickly by inhibiting viral replication should limit transmission.Further study of the new COVID-19 drugs is under way for potential use in lower-risk individuals and as preventive medications. The development of HIV antivirals also led to the development of “post-exposure prophylaxis,” a strategy in which people who have come in contact with that virus take antivirals to avoid becoming HIV-positive. The new COVID drugs have at least the potential to provide a similar benefit. Moreover, the development of these two antivirals is spurring research on other COVID-19-specific antivirals. So despite the arrival of Omicron, we still have grounds for optimism. Last year ended with the authorization of highly effective COVID-19 vaccines, and 2021 should end with the availability of highly effective, targeted COVID-19 treatments that will help the world live with COVID-19.
Opinion: End of an era? Questions mount for Pete Carroll, Russell Wilson amid Seahawks' struggles
The Seahawks don't have much hope remaining entering Monday night's game, and a lost season will spark questions for Russell Wilson and Pete Carroll.
NFL Week 12 winners and losers: Bill Belichick has Patriots rolling. Wounded Titans are in a freefall.
Behind rookie QB Mac Jones and a strong defense, the Patriots look dangerous. The win-now Rams, meanwhile, have issues to resolve.
"Good reason to be worried" as Omicron COVID variant spreads fast
But South Africa, after quickly detecting and reporting the strain, feels punished for its sound science as other nations slam the door shut.
'I Made a $4million Chess Set'
The set has 20,000 diamonds of different sizes across the 32 pieces; that's a lot of stone setting. I had to assemble a small team of highly skilled setters to help me put the diamonds in absolutely perfectly.
Dems’ dicey decision: Punish Boebert or not?
And the Senate stares down a December pileup.
Commentary: What virtual reality and artificial intelligence will mean for sex, love and intimacy
Enormous advances in technology could transform the world that began with chatbots and sex robots.
Video of Nancy Mace's Differing Vaccine Remarks on Fox News and CNN Goes Viral
Nancy Mace was criticised by a Johns Hopkins surgeon Joseph Sakran and dubbed "reckless."
Cristiano Ronaldo benching for Manchester United causes fierce debate between pundits
Cristiano Ronaldo's benching in Manchester United's 1-1 draw against Chelsea on Sunday prompted a fierce debate between leading pundits Jamie Carragher and Roy Keane.
Op-Ed: Payouts for whistleblowers aren't enough. Workers need to know they can make a difference
That's the only reliable way to marshal insiders as corporate watchdogs.
Roe v. Wade Being Overturned Will Harm Black Women the Most
Mississippi has asked the Supreme Court to overturn the landmark 1973 ruling in a case seeking to revive a 15-week abortion ban.
Biden's agenda brings warring conservative factions together in quest to flip House
The US Chamber of Commerce last year endorsed 23 vulnerable freshman House Democrats -- the most in at least a decade -- and enraged House GOP Leader Kevin McCarthy and other top Republicans who accused their long-time big business allies of heresy.
Jussie Smollett taking the stand could be a double-edged sword in alleged hate crime hoax case, attorneys say
The trial of Jussie Smollett kicks off on Monday, nearly three years after the 39-year-old actor allegedly orchestrated a hate crime against himself, telling police that two White men in MAGA hats attacked him, shouted slurs, and put a noose around his neck.
Big pharma isn't the only powerful player in the prescription drug pricing fight
A well-funded counteroffensive is being waged by powerful collection of patient groups, health insurers, hospitals, other health-care interests and AARP. And they've arguably won the first round.
What to know from NFL Week 12: The Rams are spiraling, and the 49ers are surging
Plus, Ben Roethlisberger and Cam Newton had rough outings, the Cowboys caught a break, and the Dolphins showed they aren't dead yet.
Finding someone to handle your end-of-life, after-death affairs when you have no friends or relatives
REAL ESTATE MATTERS | Without friends or family, you’ll need to find support. And you may need two different kinds of help, because you could potentially have a situation where you need one type of assistance while you are alive and another after you have died.
Editorial: Please Supreme Court, do not take abortion rights away from any women, anywhere
The Supreme Court is hearing a case asking it to overturn Roe vs. Wade, but it should reject it and continue to protect access to abortion.
Pa. commissioners called LGBTQ gathering a ‘hate group’ and denied funds to library where it was to meet. So citizens stepped in.
Fundraising campaigns have brought in $40,000 for the small library, far exceeding the $3,000 that was rejected by the local government.
Countries Close Borders as More Omicron Cases Emerge
Scotland said it had found six cases of the new variant and that contact tracing was underway. Japan barred all foreign travelers, and Australia delayed reopening its borders for two weeks.
‘Insecure’ and the defiant come-up of Issa Rae
"Insecure's" Issa Rae has come a long way since "The Misadventures of Awkward Black Girl."
Letters to the Editor: Critical race theory's loudmouth critics are making teachers' jobs impossible
Educators and administrators develop curriculum carefully. Demands to ban critical race theory from the classroom circumvent that process
Letters to the Editor: If we made more stuff in the U.S., would we even have a supply crisis?
Don't overthink the supply crisis. If the investor class hadn't outsourced jobs, our consumer items wouldn't all have to do go through a few ports.
Biden says that the infrastructure bill shows the presidency can deliver for ‘all Americans’
There's a history behind that vision.
What The Democrats Don't Get | Opinion
Congressional Democrats are willing to throw their seats away in the next election by sticking with Biden's program.
Shop lululemon’s best picks for Cyber Monday 2021: Leggings, bras, more
lululemon has Cyber Monday deals on leggings and more to get your Christmas shopping done early in 2021.
Before the pandemic, we’d dismiss a scratchy throat. Now, the sniffles can derail plans.
The endless brain game of assessing infection risks to ourselves and others could be here to stay.
What Happens When You’re the Investment
Alex Masmej revered Steve Jobs—his favorite shirt was emblazoned with Apples that changed the world: Adam’s, Isaac’s, Steve’s. Masmej dreamed of moving to Silicon Valley to start his own company, but he just didn’t have the money. In April 2020, as the world reeled from the coronavirus pandemic, Masmej found himself stuck in his home city of Paris.So Masmej did something few 23-year-olds would think to do: He tokenized himself. That is, he created a financial instrument known as a social token, a form of cryptocurrency whose value revolves around a person, to sell shares in himself. Holders of $ALEX would receive 15 percent of Masmej’s income for the next three years, capped at $100,000 overall, and would be able to exchange tokens for special privileges: 10,000 $ALEX bought a retweet from Masmej on Twitter; 20,000 $ALEX, a one-on-one conversation with him; 30,000 $ALEX, an introduction to someone in his network. In five days, Masmej raised $20,092, enough to send him across the Atlantic to San Francisco to launch his start-up.I work as a venture capitalist in Silicon Valley, and I met Masmej in San Francisco. When he shared his story with me, I was struck by what Masmej’s path to California signaled. Rather than borrowing money from investors, friends, or family, Masmej made himself the investment.This may sound dystopian to some, the plotline of a Black Mirror episode. But social tokens are part of a broader and fundamentally positive phenomenon: everyone is becoming an investor. Over time, wealth has accumulated with a select few—the investing class—while the rest of America rents time as salaried and hourly workers. Only one in two Americans has any exposure to the stock market, and that exposure is stratified by income: Just 15 percent of families in the bottom 20 percent of income earners hold stock, compared with 92 percent of families in the top 10 percent.But moves by Masmej and others like him point to a shift. More and more of the world is becoming financialized, allowing people to invest not just in companies or government bonds but also in art, collectibles, and celebrities. Parallel shifts in culture and technology are forging a new paradigm. The rules around how we create and capture economic value are being rewritten, opening up new roads to the kind of wealth creation previously limited to a select few.Today’s youth are leading this transformation by rejecting long-held beliefs: that you should stay with a corporation until you’re ready to collect your pension; that you should spend the hours of 9 to 5 chained to your desk; that you should work for anyone at all. Nearly 80 percent of teenagers say they want to be their own boss; 40 percent aspire to start their own business. Young people watched their parents and grandparents get burned during the Great Recession and again during the pandemic. They harbor a certain cynicism: One 16-year-old mocked me recently for denoting laughter with
Hill Staffers Are Wearing Sneakers Now
Congress has never been a place known for cutting-edge fashion. Instead, a stuffy formality has long been its trademark. As Allbirds and preppy quarter-zips swept into boardrooms and C-suites across the rest of the country, Capitol Hill remained one of the last bastions of traditional American business attire—the global headquarters of wing tips and ill-fitting suits, Tory Burch flats and bland Banana Republic pencil skirts. During sweltering D.C. summers, you could find communications directors and legislative aides wearing jackets and ties to work, wiping their sweaty brows on their uncuffed sleeves as the dew point climbed. The Hill is perhaps the last workplace in the country whose young employees still use the word slacks.But just like so many other great American traditions, Capitol Hill’s staid dress code has been disrupted by the coronavirus pandemic. Since most of the Hill has returned to working in person, a casualness has spread among some staffers. The trend is slight enough to be imperceptible in fancier quarters, such as parts of the Senate and most House leadership offices. And the change is unevenly distributed because every office on the Hill is essentially its own fiefdom, with its own standards for professional attire. But the shift is real—and it extends far beyond fashion.After more than a year of working remotely, often in sweats or shorts, “I don’t care to put on form-fitting pants anymore,” one senior staffer to a Democratic House lawmaker told me. Like many other offices, at least on the Democratic side, this staffer’s team transitioned back to in-person work in early summer. “It is not the same place it once was, where everyone feels like they have to be buttoned-up all the time,” he said. The senior staffer and his colleagues have started dressing more informally around the office, occasionally wearing black jeans, sneakers, and short-sleeved shirts without ties. It’s still bad form to interact with members or show up to the House floor looking like you’re at a Miami nightclub. But it’s happened. Once, the senior staffer wore shorts and a short-sleeved shirt to the Hill, expecting to spend most of the day at his desk. Then, at the last minute, he was called to the floor to bring something to his boss. On the way, lots of people witnessed his ultracasual look. Representative Madison Cawthorn, the 26-year-old Republican from North Carolina, stopped to shake his hand. The staffer was embarrassed, but the feeling wore off quickly. “Ever since that moment, I was like, I don’t care,” he said. Now that autumn is here, he’s opting for turtlenecks and blazers.The changes only go so far. Most of the Hill employees I interviewed for this story requested anonymity because they didn’t want their bosses to be associated with a story about what is widely—and incorrectly—viewed as a frivolous topic. But dress-code tweaks can have real economic and political impacts. Dressing more casually—say, investing in just one or two Bonobos suits instead of several—will save chronically underpaid Hill staffers money. Congressional positions, which have traditionally been dominated by the children of the wealthiest Americans, might become more widely accessible to poor and middle-class people. Another House aide to a Democrat told me that, before the pandemic, she wore pumps and dresses to work every day. Now that she’s back in the office, she wears mostly ballet flats and pants to escort her boss to meetings. Her colleagues are doing the same, opting for Rothy’s ankle boots instead of heels, and cozy fall sweaters instead of button-down blouses. Some aides wear leggings on recess days. “You’re keeping dry-cleaning bills down,” she told me. “You’re having things that meet multiple functions. That’s been helpful on the budget.” She’s started wearing a lot less makeup, too, switching from a cream foundation to a powder bronzer because it provides lighter coverage and doesn’t rub off under her mask. “I’m still always professional and put-together,” she said. But “I’ve been prioritizing flexibility.”[Read: What do you wear to the reopening of society?]Not all Hill aides are wearing leggings to work. Just like the states they represent, each office in Congress is governed by its own set of rules. Some members view their staff as a reflection of themselves: Lawmakers in leadership roles demand a classy entourage. Lawmakers who want leadership roles require their staff to look the part. Many Hill aides simply don’t want to go casual, arguing that dressing up is part of the job when you work in the seat of American democracy. People don’t think very highly of Congress to begin with, one aide to a Republican senator told me. Why make it worse? “Government officials ought to keep a certain level of decorum as people that are creating our laws,” he said.The Hill’s enhanced casualness is more visible among staffers for Democrats than for Republicans, according to the employees I interviewed, given that more GOP offices worked in person during the pandemic. An even more glaring fashion divide between the parties is that, on the House side where masks are required, Democratic aides generally wear them and Republican aides usually don’t. “In normal times, everybody’s wearing their business attire and you don’t know who’s a Republican or a Democrat,” Patrick Malone, the communications director for Representative Jim Himes of Connecticut, told me. “Now the battle lines are clearly drawn.”The Hill’s sartorial evolution has coincided with a bigger and potentially longer-lasting shift: Congress is tech-savvy now—or at least savvier than before. The pandemic forced lawmakers to learn how to use videoconferencing tools such as Cisco Webex and Zoom for remote hearings and committee meetings. These tools allowed witnesses to testify from anywhere, and lawmakers to do more TV hits on news stations in their own district without having to fly home. Members of Congress are now able to sign onto bills electronically, something they couldn’t do before. And House leadership expanded the use of proxy voting during the pandemic, which members from both sides of the aisle have used throughout the past 19 months. “Implementing technology like that should have been done years ago,” Representative Derek Kilmer, the chair of the Select Committee on the Modernization of Congress, told me this week. Before COVID, many offices didn’t even have laptops or videoconferencing. “There’s a meeting back in my district tonight that I wouldn’t have been able to participate in,” he said. “That can and should be here to stay.”[Read: Another truth about remote work]The pandemic has proved that many American workers can do their jobs just as well from home—and that includes congressional staff. Sure, remote work has some downsides: Politics is a business best conducted in person. But the aides I spoke with all hope to retain a remote-work option, even after the virus clears. Writing speeches and doing research are easier without all the background noise of a congressional office—the ringing phones and C-SPAN blaring from three different computers. Plus, people appreciate the flexibility. “I have a 40-minute commute each way, and if I don’t do that, I can start earlier or work later,” Malone said. “If I need to change the laundry, I can do that.”Remote work has allowed staffers to escape the Beltway more frequently, and experience a healthy jolt of reality. “It’s good to be outside this place, because you begin to think what’s in Politico Playbook or Punchbowl is actually what people are talking about,” the senior staffer said. “The time you get to spend out there is great for your ability to legislate and message. You can [ask]: ‘How’s the child tax credit affecting your family? Are you feeling it?’” Some offices have even been hiring interns and aides to work remotely, opening up a world of opportunity for people who can’t afford to live in one of the most expensive cities in America.The virus suddenly and aggressively dragged Congress into the 21st century. But the institution still has a long way to go. Although some members have embraced Blundstones in the office and hired interns to clock in from 600 miles away, others have been much, much slower to adapt. “If you want Congress to modernize completely, you need some umbrella rules that everyone has to follow,” the senior staffer said. By now, he added, “my office is as modern as it can go … But I don’t have that hope for all offices.” It’ll take more than a global pandemic to make that kind of change.
Trump allies work to place supporters in key election posts across the country, spurring fears about future vote challenges
If they succeed, the former president and his backers could pull down some of the guardrails that prevented him from overturning President Biden’s victory, critics say.
Democratic midterm fears mount as policies fail to resonate with voters
Democrats are eager to tout the bills they have passed in Biden’s first year, but a strategy tying together the disparate pieces of legislation is still lacking.
Joe Biden was involved in a deal with a Chinese giant — and was expecting a 10 percent cut
Hunter Biden and his Uncle Jim were already waiting for Tony Bobulinski in the lobby bar of the Beverly Hilton when he arrived at 10 p.m. on May 2, 2017.
Steven Bannon Faces Over 1,000 Pages of Evidence and Materials From Prosecution in Contempt Case
The Justice Department said it has handed over 65 documents per Bannon's defense team's request, while also accusing them of "frivolous" legal complaints.
Dear Care and Feeding: I’m Totally Overshadowed by My MIL on Christmas
Parenting advice on Christmas with in-laws, cultural appropriation, and family wills.
Who is Ghislaine Maxwell? Socialite and ex-girlfriend of Jeffrey Epstein goes on trial
British socialite Ghislaine Maxwell has gained global notoriety as the former girlfriend and social companion of the convicted pedophile and disgraced financier Jeffrey Epstein.
1 h